Aspirin survival in human blood modulated by the concentration of erythrocytes
โ Scribed by Patrick B. Costello; Floyd A. Green
- Publisher
- John Wiley and Sons
- Year
- 1982
- Tongue
- English
- Weight
- 466 KB
- Volume
- 25
- Category
- Article
- ISSN
- 0004-3591
No coin nor oath required. For personal study only.
โฆ Synopsis
Abstract
In vitro aspirin hydrolysis rates were measured in fresh human whole blood and in its separate components. The halfโlife of aspirin in whole blood was relatively rapid (mean 22.2 ยฑ 3.9 minutes) and exhibited a significant negative correlation with hematocrit (r = โ0.96). Hydrolysis of aspirin in buffer that contained only washed red blood cells (40%) was significantly more rapid (mean halfโlife 17.5 ยฑ 2.0 minutes) than that in whole blood. When aspirin was incubated in solutions of washed red blood cells that contained human serum albumin in various concentrations, the aspirin halfโlife was found to vary directly with the concentration of albumin used; at normal levels of albumin, the hydrolysis rate of aspirin approximated that measured in whole blood. The presence of diisopropyl fluorophosphate in low concentrations (0.02โ0.05 m__M__) markedly inhibited the rate of aspirin hydrolysis in washed red blood cells and whole blood. We conclude that enzyme(s) linked to the erythrocyte, probably membraneโbound acetylcholinesterase, control the survival of aspirin in blood.
๐ SIMILAR VOLUMES
The effects that haemoglobin-metabolite interactions have on estimates of free magnesium-ion concentration in human erythrocytes, determined by 31P NMR [Gupta, R. K. et al., J. Biol. Chem. 253, 6172-6176 (1978)], were investigated. If the metabolite-haemoglobin association constants of Berger et al.
The flavonoids silymarin, myricetin, quercetin, kaempferol, rutin, and kaempferol-3-rutinoside have been examined in combination with the food mutagens 3-amino-1-methyl-5H-pyrido (4,3-b)indole (Trp) and 2-amino-3-methylimidazo-4,5-f)quinoline (IQ) in the Comet assay in human lymphocytes from donors
Low cerebral uptake of some therapeutic drugs can be enhanced by modulation of P-glycoprotein (P-gp), an ATP-driven drug efflux pump at the blood-brain barrier (BBB). We investigated the possibility of increasing cerebral uptake of the beta-adrenergic ligands S-1'-[(18)F]-fluorocarazolol (FCAR) and